<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-133X</issn>
<issn pub-type="epub">1740-634X</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29114104</article-id>
<article-id pub-id-type="pmc">5916354</article-id>
<article-id pub-id-type="pii">npp2017276</article-id>
<article-id pub-id-type="doi">10.1038/npp.2017.276</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Bidirectional Regulation of Aggression in Mice by Hippocampal Alpha-7 Nicotinic Acetylcholine Receptors</article-title>
<alt-title alt-title-type="running">Aggression regulation by hippocampal α7 receptors</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lewis</surname>
<given-names>Alan S</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7165-5376</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pittenger</surname>
<given-names>Steven T</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mineur</surname>
<given-names>Yann S</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stout</surname>
<given-names>Dawson</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Philip H</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Picciotto</surname>
<given-names>Marina R</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4404-1280</contrib-id>
</contrib>
<aff id="aff1"><label>1</label><institution>Department of Psychiatry, Yale University School of Medicine</institution>, New Haven, CT, <country>USA</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Community Health and Social Medicine, CUNY School of Medicine</institution>, New York, NY, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Department of Psychiatry, Yale University School of Medicine</institution>, 34 Park Street, 3rd Floor Research, New Haven, CT 06508, <country>USA</country>, Tel: +203-737-2041, Fax: +203-737-2043, E-mail: <email>marina.picciotto@yale.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>05</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epreprint">
<day>07</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>12</month>
<year>2017</year>
</pub-date>
<volume>43</volume>
<issue>6</issue>
<fpage>1267</fpage>
<lpage>1275</lpage>
<history>
<date date-type="received">
<day>08</day>
<month>07</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>06</day>
<month>10</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 American College of Neuropsychopharmacology</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>American College of Neuropsychopharmacology</copyright-holder>
</permissions>
<abstract>
<p>Humans with 15q13.3 microdeletion syndrome (15q13.3DS) are typically hemizygous for <italic>CHRNA7</italic>, the gene coding for the α7 nicotinic acetylcholine receptor (nAChR), and manifest a variable neuropsychiatric phenotype that frequently includes persistent aggression. In mice, nAChR activation by nicotine is anti-aggressive, or ‘serenic,’ an effect which requires α7 nAChRs and is recapitulated by GTS-21, an α7 nAChR partial agonist. Pharmacotherapies potentiating α7 nAChR signaling have also been shown to reduce aggression in human 15q13.3DS. These findings identify the α7 nAChR as an important regulator of aggressive behavior, but the underlying neurobiological substrates remain to be determined. We therefore investigated the brain regions and potential neural circuits in which α7 nAChRs regulate aggressive behavior in male mice. As in 15q13.3DS, mice heterozygous for <italic>Chrna7</italic> were significantly more aggressive compared to wild-type controls in the resident-intruder test. We subsequently examined the hippocampus, where α7 nAChRs are highly expressed, particularly in GABAergic interneurons. Resident–intruder interactions strongly activated granule cells in the dentate gyrus (DG). In contrast, GTS-21, which reduces aggression in mice, reduced DG granule cell activity during resident–intruder interactions. Short hairpin RNA knockdown of <italic>Chrna7</italic> in the DG enhanced baseline aggression and eliminated the serenic effects of both nicotine and GTS-21 on attack latency. These data further implicate α7 nAChRs in regulation of aggression, and demonstrate that hippocampal α7 nAChR signaling is necessary and sufficient to limit aggression. These findings suggest that nAChR-mediated regulation of hippocampal excitatory–inhibitory balance could be a promising therapeutic intervention for aggression arising in certain forms of neuropsychiatric disease.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>